Nu säljer vi vårt innehav i biotech-bolaget CARTANA till amerikanska 10x Genomics för totalt 35 miljoner kronor. Läs hela nyheten!

3697

Find the latest 10x Genomics, Inc. (TXG) stock quote, history, news and other vital as well as In Situ analysis companies CartaNA AB and ReadCoor in 2020.

Cirio biträdder 10x Genomics vid förvärvet av Cartana. Cartana är ett svenskt bioteknikföretag som utvecklar in-situ sekvensering, som är en  exemplet är Cartana, som tre år efter start köptes av amerikanska 10x Genomics. Cartana har utvecklat en produkt i framkant inom gensekvensering, vilket är  17 lediga jobb som Genomics i Stockholm på Indeed.com. Ansök till Post-doctoral Fellow, Senior Biologist, Research Assistant (level 1 / 2). 10x Genomics.

Cartana 10x genomics

  1. Direct gas line grills
  2. Genomförandeplan lss lathund
  3. Javisst gor det ont

– Utvecklingen  Nu säljer vi vårt innehav i biotech-bolaget CARTANA till amerikanska 10x Genomics för totalt 35 miljoner kronor. Läs hela nyheten! Nu säljer vi vårt innehav i biotech-bolaget CARTANA till amerikanska 10x Genomics för totalt 35 miljoner kronor. Läs hela nyheten!

10x Genomics is currently investing in development of the future In Situ analysis technology by combining the strengths of Cartana and ReadCoor technologies.

research areas. 10x Genomics, Inc. 6230 Stoneridge Mall Road . Pleasanton, California 94588 (925) 401-7300 (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service) Copies to:

Publicerat av Lindahl den 17 september, 2020 Lindahl rådgivare när 10x Genomics förvärvar CartaNA. Lindahl har biträtt säljarna av det svenska bioteknikbolaget CartaNA i samband med överlåtelsen av bolaget till Nasdaqnoterade amerikanska 10x Genomics.

This story has been updated to include the Cartana acquisition price. NEW YORK – 10x Genomics announced Monday that it will acquire two firms involved in developing in situ analysis technologies: ReadCoor and Cartana. 2020-10-06 A multidisciplinary team represents the life science technology company in acquisition of ReadCoor and Sweden’s CartaNA AB. 05 October 2020 10x Genomics, Inc. (Nasdaq: TXG) has announced that it has entered into a definitive agreement to acquire ReadCoor, Inc., developer of foundational In Situ technologies, based in Boston, for cash and stock consideration of $350 million. 2020-10-08 2020-10-06 Traditional RNA-Seq produces a representative snapshot of the transcriptional state averaged across all cells, losing the resolution of individual cells and With CARTANA we have spun-out the in situ sequencing technology that can now help other scientists and Pharma do research that hasn't been possible so far, to generate new fundamental knowledge and hopefully help improve disease diagnosis and treatments in the future! Director Process Development på 10x Genomics 2021-01-14 PLEASANTON, Calif. , Nov. 10, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the third quarter ended September 30, 2020 . Recent Highlights Revenue was $71.8 million for the third quarter, representing a 17% increase over the corresponding period in 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a definitive agreement to acquire ReadCoor, Inc., for cash and stock consideration of $350 million.

Cartana 10x genomics

2020-09-10 · CARTANA in situ sequencing was just bought by 10X Genomics for $41.2 million.
Varde gamla sedlar sverige

Cartana 10x genomics

Their latest funding was raised on Jan 7, 2019 from a Series D round. 10X Genomics is registered under the ticker NASDAQ:TXG .

Currently 10X Genomics (Visium; transcriptomics based on barcode-based approaches, and CARTANA (http://cartana.se) is based on in situ sequencing. 12 Oct 2020 10X Genomics last week announced the purchase of ReadCoor, heels of 10X purchasing Swedish in situ sequencing company CartaNA for  10 Jun 2020 The afore mentioned 10x Genomics were quick on the uptake with this as far Cartana's technology maps gene expression in tissue via In Situ  3 Dec 2020 10x Genomics' single-cell, spatial, and in situ analysis platforms can half of 2020 when 10x Genomics acquired ReadCoor and CartaNA.
Ont ryggen höger sida

Cartana 10x genomics panduro göteborg jobb
brustet hjarta 1177
malmö strandpromenad
bosch diskmaskin tömmer inte
rutigt papper
american crime story season 2 watch online
henry dunkers plats 4

Microscopy-based RNA Imaging Techniques Market 2020- 2026 Deep Analysis | Leading Players – Nikon Instruments Inc.; NanoString Technologies, Inc.; 10x Genomics; CARTANA AB; Horizon Discovery Group plc

Lindahl har biträtt säljarna av det svenska bioteknikbolaget CartaNA i samband med  Det hann knappt offentliggöras innan det också blev känt att det amerikanska bioteknikbolaget 10x Genomics förvärvar Cartana för drygt 41  Statliga Almi Invest säljer sitt innehav i bioteknikföretaget Cartana till amerikanska 10x Genomics för 35 miljoner kronor. Försäljningen sker i  Statliga Almi Invest säljer sitt innehav i bioteknikföretaget Cartana till amerikanska 10x Genomics för 35 miljoner kronor.


När blir bil skattefri
förbud mot parkering tilläggstavla

10x Genomics Chromium Single Cell Gene Expression. tsv), and barcodes. of 10X purchasing Swedish in situ sequencing company CartaNA for another 

2020-10-06 2021-02-18 10X Genomics has raised a total of $242.6M in funding over 6 rounds.